July 27, 2025
5 min read
@CryptoRank_io
A .8B asset manager invests in three key companies and highlights AI, blockchain, crypto, and GLP-1 drugs as major disruptors.
$7.8B Asset Manager Invests in Thermo Fisher, Applied Materials & S&P Global, Highlights Massive Industry Disruptors
The CEO of a $7.8 billion asset management firm, Aureus Asset Management, has revealed that his company is investing heavily in three companies positioned to drive transformative advancements in healthcare, financial data, and artificial intelligence (AI). Thad Davis, Aureus' chief executive, told Barron’s that the firm has significantly invested in Thermo Fisher Scientific (TMO). He believes Thermo Fisher is on track to become the "Amazon-type" supplier for healthcare firms, providing all the essential materials, equipment, and supplies needed in lab environments."If you ever watch the dollies that come in and out of a hospital or biotech building, they are loaded with Thermo Fisher equipment."The second key investment is Applied Materials (AMAT), a company critical to the development of powerful chips amid the AI boom. While Nvidia currently leads chip manufacturing, Davis emphasized Applied Materials’ indispensable role across four critical stages of chip production, ensuring sustained demand regardless of which company dominates the market. Lastly, Aureus is bullish on S&P Global (SPGI), which holds a dominant position in the credit ratings market alongside Moody’s, forming a near duopoly. Davis also highlighted three broader investment themes that Aureus is monitoring closely for their disruptive potential:
- Artificial Intelligence (AI)
- Blockchain and cryptocurrency
- GLP-1 drugs, which are medicines designed to treat diabetes and obesity
- Crypto Giants Accelerate Drive for Real-World Asset Tokenization
- AI-Driven Crypto Trading Tools Reshape Market Strategies in 2025
- Magentic Raises $5 Million for AI Agents in Supply Chains
"Each taken separately has the capacity to profoundly disrupt various industries. But some taken together could have the same impact. GLP-1s and AI might be amazingly helpful in revolutionizing therapeutic developments, for example."Aureus Asset Management is a Boston-based wealth management firm serving high-net-worth individuals, families, and institutions. Source: Originally published at The Daily Hodl on July 27, 2025.